Algernon Pharmaceuticals Ifenprodil Chronic Cough Study Receives Positive Feedback from U.S. FDA
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news that the Company has received positive feedback from the U.S. Food and Drug Administration at their Pre-Investigational New Drug meeting regarding the use of Ifenprodil for the treatment of chronic cough.
